SCHEMBL29077243

SCHEMBL29077243

ClCc1nnc(-c2ccccc2I)o1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.59
LMNA P02545 1/20 0.59
SMN1; SMN2 Q16637 8/20 0.46
NPC1 O15118 7/20 0.46
RAB9A P51151 7/20 0.46
HPGD P15428 6/20 0.46
TSHR P16473 4/20 0.46
MAPK1 P28482 2/20 0.46
NOTUM Q6P988 3/20 0.45
THRB P10828 1/20 0.43
TP53 P04637 1/20 0.43
GPR55 Q9Y2T6 1/20 0.41
KDM4E B2RXH2 2/20 0.41
POLB P06746 1/20 0.41
PKM P14618 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
C1R P00736 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2406430 0.81 SMN1; SMN2 (0.69) ALDH1A1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL30566761 0.81 SMN1; SMN2 (0.69) ALDH1A1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL28529043 0.79 HPGD (0.61) ALDH1A1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL27475343 0.79 ALDH1A1 (0.59) ALDH1A1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL11920156 0.79 RAB9A (0.67) ALDH1A1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL27918922 0.79 HPGD (0.64) ALDH1A1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL5901255 0.76 ALDH1A1 (0.54) ALDH1A1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL485159 0.74 ALDH1A1 (1.00) ALDH1A1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL29256146 0.73 ALDH1A1 (0.64) ALDH1A1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL29077285 0.73 L3MBTL1 (0.62) ALDH1A1LMNASMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240300932-A1 N-PHENYLIMINE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF GUIZHOU UNIVERSITY (CN) 2024-09-12 US disclosed
WO-2024174317-A1 N-PHENYLIMINE-CONTAINING DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF 贵州大学 2024-08-29 WO disclosed
CN-116731003-A N-phenylimine-containing derivative, and preparation method and application thereof 贵州大学 2023-09-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240300932-A1 N-PHENYLIMINE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF PNMT, NNMT, PAH ALDH1A1 780/4885LMNA 2548/4885SMN1; SMN2 1700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.